88 related articles for article (PubMed ID: 24582430)
1. [Neurofibromatosis type 2 and its head and neck manifestations: literature review and population study in the Community of Cantabria and the province of Las Palmas].
Guerra-Jiménez G; Camargo Camacho P; Ramos-Macías Á; Morales Angulo C
Acta Otorrinolaringol Esp; 2014; 65(3):148-56. PubMed ID: 24582430
[TBL] [Abstract][Full Text] [Related]
2. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
3. [Ear, nose and throat manifestations of Wegener's granulomatosis (granulomatosis with polyangiitis)].
Morales-Angulo C; García-Zornoza R; Obeso-Agüera S; Calvo-Alén J; González-Gay MA
Acta Otorrinolaringol Esp; 2012; 63(3):206-11. PubMed ID: 22439922
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
5. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
6. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
7. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.
Nagato T; Katada A; Yoshizaki T; Kunibe I; Takahara M; Katayama A; Hayashi T; Harabuchi Y
Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213
[TBL] [Abstract][Full Text] [Related]
8. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434
[TBL] [Abstract][Full Text] [Related]
9. [Difficulties of the management of head and neck neurofibromatosis].
Jeblaoui Y; Neji B; Haddad S; Mnif D; Hchicha S
Ann Chir Plast Esthet; 2007 Feb; 52(1):43-50. PubMed ID: 17137698
[TBL] [Abstract][Full Text] [Related]
10. Hearing preservation in neurofibromatosis type 2.
Slattery WH; Brackmann DE; Hitselberger W
Am J Otol; 1998 Sep; 19(5):638-43. PubMed ID: 9752973
[TBL] [Abstract][Full Text] [Related]
11. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
[TBL] [Abstract][Full Text] [Related]
12. Management strategies in neurofibromatosis type 2.
Moffat DA; Quaranta N; Baguley DM; Hardy DG; Chang P
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):12-8. PubMed ID: 12520350
[TBL] [Abstract][Full Text] [Related]
13. Hearing preservation and tumour control after radiosurgery for NF2-related vestibular schwannomas.
Massager N; Delbrouck C; Masudi J; De Smedt F; Devriendt D
B-ENT; 2013; 9(1):29-36. PubMed ID: 23641588
[TBL] [Abstract][Full Text] [Related]
14. [Otorhinolaryngological manifestations in patients with Behçet disease].
Morales-Angulo C; Vergara Pastrana S; Obeso-Agüera S; Acle L; González-Gay MÁ
Acta Otorrinolaringol Esp; 2014; 65(1):15-21. PubMed ID: 24094428
[TBL] [Abstract][Full Text] [Related]
15. Auditory brainstem implants in NF2 patients: results and review of the literature.
Sanna M; Di Lella F; Guida M; Merkus P
Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
[TBL] [Abstract][Full Text] [Related]
16. Otolaryngological, head and neck manifestations in HIV-infected patients seen at Steve Biko Academic Hospital in Pretoria, South Africa.
Tshifularo M; Govender L; Monama G
S Afr Med J; 2013 May; 103(7):464-6. PubMed ID: 23802209
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
[TBL] [Abstract][Full Text] [Related]
18. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
19. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
